Relpax and Stadol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax and Stadol. Common interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people who take Relpax and Stadol have. It is created by eHealthMe based on reports of 11 people who take Relpax and Stadol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

11 people who take Relpax and Stadol together, and have interactions are studied.


What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 8,804 Relpax users for its effectiveness, alternative drugs and more.

What is Stadol?

Stadol has active ingredients of butorphanol tartrate. It is often used in migraine. eHealthMe is studying from 5,524 Stadol users for its effectiveness, alternative drugs and more.

Number of Relpax and Stadol reports submitted per year:

Relpax and Stadol drug interactions.

Common Relpax and Stadol drug interactions by gender *:

female:

  1. Drug ineffective
  2. Nausea
  3. Amnesia
  4. Anxiety
  5. Arthralgia
  6. Bipolar disorder
  7. Brain neoplasm
  8. Candidiasis
  9. Cholelithiasis
  10. Constipation

male:

n/a

Common Relpax and Stadol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Adjustment disorder
  2. Brain neoplasm
  3. Candidiasis
  4. Cholelithiasis
  5. Constipation
  6. Dependent personality disorder
  7. Diabetes mellitus
  8. Drug abuse
  9. Dysthymic disorder
  10. Dysuria

40-49:

  1. Arthralgia
  2. Drug ineffective
  3. Face oedema
  4. Fatigue
  5. Hypersomnia
  6. Malaise
  7. Oedema
  8. Oedema peripheral
  9. Pain in extremity
  10. Sensation of heaviness

50-59:

  1. Abdominal distension
  2. Dyspnoea
  3. Fatigue
  4. Flight of ideas
  5. Gastrooesophageal reflux disease
  6. Headache
  7. Hypertension
  8. Insomnia
  9. Muscle spasms
  10. Nausea

60+:

  1. Drug ineffective

Common conditions people have *:

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 18.18%
  2. Stress And Anxiety: 2 people, 18.18%
  3. Depression: 2 people, 18.18%
  4. Insomnia (sleeplessness): 2 people, 18.18%
  5. Bleeding Into The Skin: 2 people, 18.18%
  6. Peripheral Swelling: 2 people, 18.18%
  7. Skin Fissures (a crack in the skin): 2 people, 18.18%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
  9. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 9.09%
  10. Dizziness: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Stadol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Relpax and Stadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Relpax side effects:

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Stadol side effects:

Browse all side effects of Stadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Relpax interactions:

Browse all interactions between Relpax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Stadol interactions:

Browse all interactions between Stadol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide and butorphanol tartrate (the active ingredients of Relpax and Stadol, respectively), and Relpax and Stadol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Relpax and Stadol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: